Clexio Biosciences Ltd.
3 clinical trials · Sponsor
◉ Watch Clexio Biosciences Ltd.
| Record | Firm | Date |
|---|---|---|
| A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder (NCT06340958) | Clexio Biosciences Ltd. | 2024-03-18 |
| A Study of CLE-400 (Topical Gel) for the Treatment of Chronic Pruritus in Adult Subjects With Notalgia Paresthetica (NCT06262607) | Clexio Biosciences Ltd. | 2024-01-29 |
| A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study (NCT04103892) | Clexio Biosciences Ltd. | 2019-09-05 |
Track Clexio Biosciences Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.